ProfileGDS4132 / 211618_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 45% 55% 42% 33% 52% 53% 42% 53% 27% 36% 14% 18% 13% 15% 10% 21% 14% 15% 18% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101119.49745
GSM201543Muscle PCOS pioglitazone 121141.20155
GSM201544Muscle PCOS pioglitazone 161110.24542
GSM201545Muscle PCOS pioglitazone 20190.114733
GSM201829Muscle PCOS pioglitazone 231150.23852
GSM201830Muscle PCOS pioglitazon 251150.3253
GSM201831Muscle PCOS pioglitazone 271110.34742
GSM201832Muscle PCOS pioglitazone 31140.75453
GSM201833Muscle PCOS pioglitazone 4162.507227
GSM201834Muscle PCOS pioglitazone 8188.301336
GSM201835Muscle PCOS after pioglitazone 10221.492814
GSM201836Muscle PCOS after pioglitazone 12232.440818
GSM201837Muscle PCOS after pioglitazone 16219.601113
GSM201838Muscle PCOS after pioglitazone 20227.409115
GSM201839Muscle PCOS after pioglitazone 23217.599910
GSM201840Muscle PCOS after pioglitazone 25245.943621
GSM201841Muscle PCOS after pioglitazone 27221.317114
GSM201842Muscle PCOS after pioglitazone 3224.048615
GSM201843Muscle PCOS after pioglitazone 4240.642718
GSM201844Muscle PCOS after pioglitazone 8239.227320